Antiarrhythmic drugs are grouped into four classes for a reason that matters clinically, not just academically - each class works through a genuinely different mechanism, which means the monitoring, contraindications, and risks differ meaningfully across them even when the end goal (a stable rhythm) looks the same. This page holds 120 questions, 30 per class, built around that distinction.
Class I Antiarrhythmics cover the sodium channel blockers, tested through their subclasses and the specific rhythm disturbances each is used for, along with the ECG changes and toxicity signs a nurse needs to monitor for. Class II Antiarrhythmics cover beta blockers used specifically for rhythm control, testing the distinction between their antiarrhythmic use and their more familiar role in hypertension management, since the monitoring priorities shift depending on which use is driving the prescription.
Class III Antiarrhythmics cover the potassium channel blockers, a class that includes some of the most powerful and most carefully monitored antiarrhythmic drugs in use, tested through the specific cardiac and non-cardiac toxicities that make careful dosing and monitoring essential. Class IV Antiarrhythmics cover the calcium channel blockers used for rhythm control, tested through their mechanism and the specific patient populations where they're contraindicated or used with particular caution.
Each class's 30 questions focus on the same core skill: connecting a drug's specific mechanism to what a nurse actually needs to watch for once it's administered. A sodium channel blocker and a potassium channel blocker can both be treating the same arrhythmia, but the ECG changes that signal developing toxicity, and the interventions that follow, are entirely different - which is exactly the distinction a real clinical scenario, and a real exam question, is built to test.
This page is built for nursing students in a pharmacology or cardiac course, and for NCLEX candidates who need to reason through antiarrhythmic mechanism and monitoring by class, not just recognize individual drug names in isolation from how they actually work.
Working through all four classes together, rather than studying whichever drug happens to come up in a clinical rotation, pays off specifically because these medications are so often used in combination or substituted for one another when a first-line choice fails. A nurse who understands why a Class III drug carries different monitoring than a Class I drug is equipped to catch a medication reconciliation error or ask the right question when a patient's regimen changes - recognition that only comes from understanding the classification system itself, not just memorizing which drug treats which rhythm.
